Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIFENTANIL vs RESMETIROM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMIFENTANIL vs RESMETIROM: Safety Overview

Metric REMIFENTANIL RESMETIROM
Total FAERS Reports 2,733 881
Deaths Reported 210 26
Death Rate 7.7% 3.0%
Hospitalizations 995 50
Average Patient Age 50.3 yrs 58.1 yrs
% Female Patients 48.2% 65.3%
FDA Approval Date Jan 16, 2018 Mar 14, 2024
Manufacturer Fresenius Kabi USA, LLC Madrigal Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription